Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
1,301
-21
-2% -$17.3K 0.01% 886
2026
Q1
$965K Buy
1,322
+162
+14% +$127K 0.01% 894
2025
Q4
$976K Sell
1,160
-38
-3% -$32.5K 0.01% 824
2025
Q3
$884K Sell
1,198
-66
-5% -$43.5K 0.01% 887
2025
Q2
$697K Buy
1,264
+154
+14% +$89.4K 0.01% 882
2025
Q1
$657K Buy
1,110
+220
+25% +$139K 0.01% 891
2024
Q4
$547K Buy
890
+62
+7% +$36.3K 0.01% 898
2024
Q3
$449K Buy
828
+154
+23% +$77.8K 0.01% 985
2024
Q2
$290K Buy
+674
New +$258K 0.01% 1138
2024
Q1
– Sell
-581
Closed -$221K – 1331
2023
Q4
$221K Buy
581
+125
+27% +$58.2K 0.01% 1168
2023
Q3
$224K Buy
+456
New +$223K 0.01% 1052

Other funds holding ARGX

Vident Advisory's ARGX Position: Q2 2026 in Review

Vident Advisory reduced its argenx (ARGX) stake by 1.6% in Q2 2026, selling an estimated $17.3K and leaving 1,301 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #886.

Vident Advisory first reported a position in ARGX in Q3 2023 and has held it in 11 quarters since. 508 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • Vident Advisory held 1,301 shares of argenx worth $1.21M as of Q2 2026.
  • Vident Advisory sold 21 argenx shares in Q2 2026, an estimated $17.3K.
  • argenx made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #886 holding.
  • Vident Advisory first reported a position in argenx in Q3 2023 and has held it in 11 quarters since.
  • 508 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.